Literature DB >> 26738840

Mycetoma: a unique neglected tropical disease.

Eduard E Zijlstra1, Wendy W J van de Sande2, Oliverio Welsh3, El Sheikh Mahgoub4, Michael Goodfellow5, Ahmed H Fahal4.   

Abstract

Mycetoma can be caused by bacteria (actinomycetoma) or fungi (eumycetoma) and typically affects poor communities in remote areas. It is an infection of subcutaneous tissues resulting in mass and sinus formation and a discharge that contains grains. The lesion is usually on the foot but all parts of the body can be affected. The causative microorganisms probably enter the body by a thorn prick or other lesions of the skin. Mycetoma has a worldwide distribution but is restricted to specific climate zones. Microbiological diagnosis and characterisation of the exact organism causing mycetoma is difficult; no reliable serological test exists but molecular techniques to identify relevant antigens have shown promise. Actinomycetoma is treated with courses of antibiotics, which usually include co-trimoxazole and amikacin. Eumycetoma has no acceptable treatment at present; antifungals such as ketoconazole and itraconazole have been used but are unable to eradicate the fungus, need to be given for long periods, and are expensive. Amputations and recurrences in patients with eumycetoma are common.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26738840     DOI: 10.1016/S1473-3099(15)00359-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  59 in total

Review 1.  Mycetoma (Madura Foot) in Israel: Recent Cases and a Systematic Review of the Literature.

Authors:  Ohad Bitan; Yonit Wiener-Well; Rina Segal; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Pyomelanin Secretion in Madurella mycetomatis Interferes with Spectrophotometric Endpoint Reading Using the Sensititre YeastOne alamarBlue Assay but Not with Visual Endpoint Reading.

Authors:  B Nyuykonge; P D Croughs; A H Fahal; A Verbon; W W J van de Sande
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

3.  Eumycetoma of the Foot due to Fusarium solani in a Person with Diabetes Mellitus: Report of a Case and Review of Literature.

Authors:  Liza Das; Divya Dahiya; Kirti Gupta; Mahesh Prakash; Bhanu Malhotra; Ashu Rastogi; Hansraj Choudhary; Shivaprakash M Rudramurthy; Pinaki Dutta
Journal:  Mycopathologia       Date:  2021-03-09       Impact factor: 2.574

4.  A Short-Tandem-Repeat Assay (MmySTR) for Studying Genetic Variation in Madurella mycetomatis.

Authors:  Bertrand Nyuykonge; Kimberly Eadie; Willemien H A Zandijk; Sarah A Ahmed; Marie Desnos-Ollivier; Ahmed H Fahal; Sybren de Hoog; Annelies Verbon; Wendy W J van de Sande; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

Review 5.  Natural-Product-Based Solutions for Tropical Infectious Diseases.

Authors:  Oyelola Adegboye; Matt A Field; Andreas Kupz; Saparna Pai; Dileep Sharma; Michael J Smout; Phurpa Wangchuk; Yide Wong; Claire Loiseau
Journal:  Clin Microbiol Rev       Date:  2021-09-08       Impact factor: 50.129

6.  Nigrograna mackinnonii, Not Trematosphaeria grisea (syn., Madurella grisea), Is the Main Agent of Black Grain Eumycetoma in Latin America.

Authors:  Sarah A Ahmed; Gloria M González; Andrés Tirado-Sánchez; Luis Miguel Moreno-López; Sybren de Hoog; Alexandro Bonifaz
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

7.  In vitro susceptibility testing for black grain eumycetoma causative agents.

Authors:  Wendy W J van de Sande
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-04-14       Impact factor: 2.184

8.  The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma.

Authors:  Mickey Konings; Kimberly Eadie; Wilson Lim; Ahmed H Fahal; Johan Mouton; Nicolas Tesse; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2021-06-09

9.  Niclosamide Is Active In Vitro against Mycetoma Pathogens.

Authors:  Abdelhalim B Mahmoud; Shereen Abd Algaffar; Wendy van de Sande; Sami Khalid; Marcel Kaiser; Pascal Mäser
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

10.  Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.

Authors:  Wilson Lim; Mickey Konings; Florianne Parel; Kimberly Eadie; Nikolaos Strepis; Ahmed Fahal; Annelies Verbon; Wendy W J van de Sande
Journal:  Med Mycol       Date:  2022-02-02       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.